Stockscreener 앱 받기
31.45
2.62%
-1.01
전일 마감가:
$32.46
열려 있는:
$31.8
하루 거래량:
66,121
Relative Volume:
0.08
시가총액:
$2.49B
수익:
$399.58M
순이익/손실:
$-54.04M
주가수익비율:
-41.93
EPS:
-0.75
순현금흐름:
$40.13M
1주 성능:
-8.85%
1개월 성능:
-10.07%
6개월 성능:
+2.36%
1년 성능:
+2.10%
1일 변동 폭
$31.39
$32.19
1주일 범위
$31.43
$34.28
52주 변동 폭
$22.61
$50.71
Veracyte Inc Stock (VCYT) Company Profile
명칭
Veracyte Inc
전화
(650) 243-6300
주소
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Compare VCYT vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
31.39 | 2.58B | 399.58M | -54.04M | 40.13M | -0.75 |
|
TMO
Thermo Fisher Scientific Inc
|
484.69 | 184.15B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
190.74 | 137.93B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
589.77 | 47.82B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
112.97 | 32.62B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
293.31 | 29.19B | 3.17B | 642.63M | 516.49M | 10.77 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 재개 | Morgan Stanley | Underweight |
| 2025-10-20 | 개시 | Canaccord Genuity | Hold |
| 2025-03-20 | 개시 | Craig Hallum | Buy |
| 2024-12-05 | 다운그레이드 | Goldman | Buy → Neutral |
| 2024-11-15 | 개시 | Wolfe Research | Outperform |
| 2024-10-16 | 개시 | UBS | Buy |
| 2024-10-10 | 개시 | Guggenheim | Buy |
| 2024-02-23 | 재확인 | Needham | Buy |
| 2023-01-18 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-01-07 | 개시 | Stephens | Overweight |
| 2021-11-18 | 재개 | Goldman | Buy |
| 2021-06-15 | 개시 | Raymond James | Outperform |
| 2021-02-18 | 재개 | Needham | Buy |
| 2021-01-28 | 개시 | Truist | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-09-09 | 개시 | Morgan Stanley | Underweight |
| 2019-07-31 | 개시 | Lake Street | Buy |
| 2019-07-02 | 개시 | Needham | Buy |
| 2018-11-29 | 다운그레이드 | Janney | Buy → Neutral |
| 2018-10-31 | 업그레이드 | Janney | Neutral → Buy |
| 2017-11-07 | 다운그레이드 | Janney | Buy → Neutral |
| 2017-11-07 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2017-08-31 | 재개 | BTIG Research | Buy |
| 2016-11-14 | 재개 | Leerink Partners | Outperform |
| 2015-12-18 | 개시 | Cantor Fitzgerald | Buy |
| 2015-06-11 | 재확인 | Leerink Partners | Outperform |
| 2013-11-26 | 개시 | William Blair | Outperform |
모두보기
Veracyte Inc 주식(VCYT)의 최신 뉴스
Veracyte, Inc. $VCYT Stock Holdings Lifted by First Trust Advisors LP - MarketBeat
Veracyte CFO Chambers sells $662k in VCYT stock - Investing.com Nigeria
Panic Selling: Can Veracyte Inc. ride the EV waveWeekly Trade Analysis & Risk Adjusted Swing Trade Ideas - baoquankhu1.vn
Veracyte at Leerink Global Healthcare: Strategic Growth Focus By Investing.com - Investing.com Canada
Are Veracyte's (VCYT) Strong 2025 Profits and Reaffirmed 2026 Outlook Redefining Its Growth Story? - simplywall.st
Insider Sell: Rebecca Chambers Sells Shares of Veracyte Inc (VCY - GuruFocus
Veracyte (NASDAQ:VCYT) Insider Sells 5,260 Shares - MarketBeat
VCYT: Morgan Stanley Lowers Price Target Amidst Underweight Rati - GuruFocus
Morgan Stanley Lowers Price Target on Veracyte to $37 From $48, Keeps Underweight Rating - marketscreener.com
Morgan Stanley cuts Veracyte stock price target on valuation methodology By Investing.com - Investing.com Canada
Morgan Stanley cuts Veracyte stock price target on valuation methodology - Investing.com
Veracyte, Inc. $VCYT Shares Sold by GW&K Investment Management LLC - MarketBeat
Veracyte, Inc. $VCYT Shares Acquired by ARK Investment Management LLC - MarketBeat
Affiliate to sell 6,658 Restricted Stock Units — VCYT (NASDAQ: VCYT) - Stock Titan
[144] VERACYTE, INC. SEC Filing - Stock Titan
Marc Stapley (NASDAQ: VCYT) reports sale of 15,000 shares for $1.92M - Stock Titan
Veracyte (NASDAQ: VCYT) VP has 3,006 shares withheld for taxes - Stock Titan
Veracyte (VCYT) CFO reports 7,234-share tax withholding, not a sale - Stock Titan
[Form 4] VERACYTE, INC. Insider Trading Activity - Stock Titan
Veracyte (VCYT) exec sells 13,425 shares, 117,346 remain - Stock Titan
Veracyte (VCYT) CEO has 19,455 shares withheld to cover taxes - Stock Titan
Segall Bryant & Hamill LLC Has $18.31 Million Stock Holdings in Veracyte, Inc. $VCYT - MarketBeat
Champlain Investment Partners LLC Makes New $40.06 Million Investment in Veracyte, Inc. $VCYT - MarketBeat
VCYT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Veracyte, Inc. (VCYT) Stock Analysis: Uncovering A Promising 34.96% Upside For Investors - DirectorsTalk Interviews
William Blair Investment Management LLC Buys New Stake in Veracyte, Inc. $VCYT - MarketBeat
Veracyte (VCYT) Valuation Check After Strong 2025 Earnings And Reaffirmed 2026 Growth Outlook - Yahoo Finance
JPMorgan Chase & Co. Has $17.81 Million Position in Veracyte, Inc. $VCYT - MarketBeat
Veracyte to Participate in the 44th Annual J.P. Morgan Healthcare Conference - Business Wire
Cathie Wood’s ARK sells Veracyte stock, buys MercadoLibre - Investing.com South Africa
Cathie Wood’s ARK sells Veracyte stock, buys MercadoLibre By Investing.com - Investing.com Nigeria
Veracyte Inc. Signals Durable Growth in Earnings Call - TipRanks
Veracyte, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:VCYT) 2026-03-02 - Seeking Alpha
Veracyte (VCYT) CCO John Leite receives PSU shares, withholds stock for taxes - Stock Titan
Veracyte (VCYT) CEO reports PSU vesting and tax withholding share disposition - Stock Titan
Veracyte (VCYT) CFO granted shares as PSUs vest, with tax shares withheld - Stock Titan
Veracyte (NASDAQ: VCYT) officer gets PSU vesting, withholds shares - Stock Titan
Veracyte (VCYT) SVP awarded 50,999 shares; some withheld for taxes - Stock Titan
How Veracyte’s Profit Jump and 2026 Outlook Will Impact Veracyte (VCYT) Investors - simplywall.st
Vanguard Group Inc. Raises Stock Holdings in Veracyte, Inc. $VCYT - MarketBeat
Veracyte, Inc. (NASDAQ:VCYT) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Veracyte Stock Soars 8.48%, Hits Intraday High of $39.89 - Markets Mojo
Veracyte (VCYT) Margin Expansion To 12.8% Tests Bullish Profitability Narratives - simplywall.st
Veracyte, Inc. (NASDAQ:VCYT) Q4 2025 Earnings Call Transcript - Insider Monkey
Decoding Veracyte Inc (VCYT): A Strategic SWOT Insight - GuruFocus
Artisan Partners Limited Partnership Acquires 1,048,692 Shares of Veracyte, Inc. $VCYT - MarketBeat
VCYT Gains Analyst Support: Needham Raises Price Target | VCYT S - GuruFocus
Veracyte Presents 15 Studies on Decipher Cancer Tests at ASCO GU Symposium - Clinical Lab Products
Veracyte Q4 Earnings Beat Estimates, Revenues Grow Y/Y, Stock Rises - Yahoo Finance
Veracyte (NASDAQ:VCYT) Shares Gap Up on Analyst Upgrade - MarketBeat
Veracyte (NASDAQ:VCYT) Price Target Raised to $48.00 - MarketBeat
Veracyte Inc (VCYT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Veracyte Inc 주식 (VCYT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Stapley Marc | Chief Executive Officer |
Mar 04 '26 |
Sale |
35.97 |
45,523 |
1,637,594 |
357,554 |
| Leite John | Chief Commercial Officer-CLIA |
Mar 04 '26 |
Sale |
35.19 |
5,260 |
185,083 |
107,580 |
| McGuire Annie | SVP, General Counsel |
Mar 04 '26 |
Sale |
35.55 |
6,658 |
236,725 |
94,706 |
0.71%
0.97%
자본화:
|
볼륨(24시간):